Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
01/2005
01/20/2005WO2005004814A2 Sirt1 and genetic disorders
01/20/2005WO2005004798A2 Methods for treating lentivirus infections
01/20/2005WO2005004794A2 Method of treating neurodegenerative disease
01/20/2005WO2005004702A2 Egr genes as targets for the diagnosis and treatment of schizophrenia
01/20/2005WO2005004641A1 Compositions and methods for tenderizing meat
01/20/2005WO2004101826A3 Methods to identify compounds that modulate the autoinducer-2 dependent quorum sensing system in vibrio harveyi
01/20/2005WO2004101820A3 Use of sah gene as a marker for psoriasis
01/20/2005WO2004099430A3 Substrate in the form of a ligate carrier
01/20/2005WO2004097042A8 Sirna selection method
01/20/2005WO2004093909A9 Methods to regulate biofilm formation
01/20/2005WO2004091150A3 Cyp2s1 as target dor diagnosis and therapy of skin diseases
01/20/2005WO2004090156A3 Test system for detecting contaminants
01/20/2005WO2004089983A3 Severe acute respiratory syndrome (sars) causing coronavirus
01/20/2005WO2004087952A8 Genes regulated by hydrogen peroxide stress
01/20/2005WO2004085673A3 Compositions and methods of using hexokinase v
01/20/2005WO2004083232A3 Receptor proteins
01/20/2005WO2004081186A8 Single nucleotide polymorphisms associated with stenosis, methods of detection and uses thereof
01/20/2005WO2004079367A8 Bioarray
01/20/2005WO2004076685A3 Fungal biosensor and assay
01/20/2005WO2004072235A3 Cotton event mon 88913 and compositions and methods for detection thereof
01/20/2005WO2004070005B1 Double ended sequencing
01/20/2005WO2004066940A3 Compositions and methods containing substituted quinolines and substituted diphenylsulfones
01/20/2005WO2004063323A3 Aflp-based method for integrating physical and genetic maps
01/20/2005WO2004057336A3 Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
01/20/2005WO2004053159A3 Oligonucleotide guided analysis of gene expression
01/20/2005WO2004048925A3 NaCT AS A TARGET FOR LIFESPAN EXPANSION AND WEIGHT REDUCTION
01/20/2005WO2004043977A3 2’-fluoro substituted oligomeric compounds and compositions for use in gene modulations
01/20/2005WO2004042070A9 Electrical detection of dna hybridization and specific binding events
01/20/2005WO2004038040A3 Enzyme array and assay
01/20/2005WO2004033709A3 Methods, probes, and kits for detecting group a streptococcus
01/20/2005WO2004026265A3 Compositions and methods for treatment of herpesvirus infections
01/20/2005WO2004024886A3 Microarray synthesis and assembly of gene-length polynucleotides
01/20/2005WO2004024864A3 Rna-cleaving dna enzymes with altered regio- or enantioselectivity
01/20/2005WO2004010848A3 Oncogenes useful for the identification of urinary bladder cancer
01/20/2005WO2003103017A3 Method and system of determining chamber seasoning condition by optical emission
01/20/2005WO2003072114A8 Vascular therapeutics
01/20/2005WO2003066881A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
01/20/2005WO2003064688A3 Method of generation and management of unique sequences in dna production
01/20/2005WO2003035848A9 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
01/20/2005US20050015832 Coding for polyol carriers in plants or fungi in polyols with main chain of 5 to 8 carbons with 6 the ideal such as manniotol
01/20/2005US20050015827 QTL "mapping as-you-go"
01/20/2005US20050015823 Screening methods employing fish model assessment of vision
01/20/2005US20050015821 Sensin polypeptides, encoding nucleic acids, mutations, and methods of their identification and use
01/20/2005US20050015820 Using transgenic mouse tissue as model for monitoring agents that affect appetite, energy expenditure and caloric and food intake; dietetics and weight gain
01/20/2005US20050015228 Method for modelling hydrocarbon degradation in an oil deposit
01/20/2005US20050015206 Nucleic acid detection assay control genes
01/20/2005US20050014935 Chimeric protein comprising amadoriase activity for use in diagnosis and prognosis of diabetic pathologies
01/20/2005US20050014821 Compounds and methods for treating neurodegenerative disorders
01/20/2005US20050014785 Treatment of radiation disorders
01/20/2005US20050014718 Tumor specific oligosaccharide sequences and use thereof
01/20/2005US20050014710 Compositions and methods relating to prostate specific genes and proteins
01/20/2005US20050014708 Inhibition of viral replication by targeting RNA-DNA complexes
01/20/2005US20050014695 Uses of a chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes
01/20/2005US20050014692 Isolate nucleic acids; intensify stimulated insulin elimination; antidiabetic agents
01/20/2005US20050014687 Nucleoc acid sequences coding polypeptides; binding to antibodies; diagnosis, therapy of diseases such as cancer
01/20/2005US20050014647 For plants; using alanine, ammonium hydroxide, asparagine and, or oxopropionic acid; measurement of acetolactic acid; calibration
01/20/2005US20050014291 Assay method using biochemical analysis units and cleaning apparatus for the same
01/20/2005US20050014258 Methods for altering cell fate
01/20/2005US20050014257 Modulation of C-reactive protein expression
01/20/2005US20050014242 Expression vector comprising nuclelotide sequences coding seriene protease for use as therapeutic protein in treatment of inflammatory, reproductive, epidermal and neurological tissue disorders
01/20/2005US20050014239 Modulation of sulfate permease for photosynthetic hydrogen production
01/20/2005US20050014238 Glycerol dehydratase for use in catalyzing the fermentation of glycerol to 1,3-propanediol in transgenic microorganism; preparing polyester fibers
01/20/2005US20050014228 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
01/20/2005US20050014223 Renilla GFP mutants with increased fluorescent intensity and spectral shift
01/20/2005US20050014222 Phosphatases which activate map kinase pathways
01/20/2005US20050014215 Chromogens; fluorogens; improved sensitivity, translucence, and stability via ready-to-use liquid or gel containing polyethoxylated fatty acid, sorbitan ester and solvent (dimethyl sulfoxide)
01/20/2005US20050014214 for evaluating the effectiveness of a sterilizer utilizing an anti-microbial gas or liquid fluid.
01/20/2005US20050014212 Such as hydrolases, oxydases, lyases, ligases, transferases, and/or isomerases; biocatalysts; incubation, development (with adrenaline), transformation; fluorescence resonance energy transfer
01/20/2005US20050014206 Method of identifying compounds that specifically inhibit the anaphase promoting complex
01/20/2005US20050014205 Diagnostic assay for measuring a cell mediated immune response
01/20/2005US20050014197 Immobilization; chelation; incubation; hybridization; chromatography; mass spectrometry; proteomics; kits
01/20/2005US20050014192 Methods and compositions for amplification of RNA sequences
01/20/2005US20050014190 Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism
01/20/2005US20050014188 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
01/20/2005US20050014187 Novel polypeptide hormone phosphatonin
01/20/2005US20050014185 Method and apparatus for nucleic acid hybridization
01/20/2005US20050014184 Arrays, computer program products and methods for in silico array-based comparative binding arrays
01/20/2005US20050014183 Mixture comprising primers, combinations of primers and/or multiplexes of primers for use as sequence propagation tools in medical, forensic and DNA tracing diagnostics; single nucleotide polymorphisms analysis
01/20/2005US20050014182 Use of calpain for identifying compounds that modulate pain
01/20/2005US20050014181 Methods and compositions for the assessment of polymer assembly
01/20/2005US20050014178 Biosensor comprising mutiple immobilized receptors for use in screening and detection of preferential polypeptides, toxins, insecticides, drugs and/or pathogens in a solution; high throughput assay
01/20/2005US20050014177 Nucleotide sequences coding high density lipoprotein regulatory molecule for use in diagnosis/prognosis, prevention and treatment of cardiovascular disorders
01/20/2005US20050014176 Method for quantitative end-point PCR
01/20/2005US20050014175 Methods and apparatuses for analyzing polynucleotide sequences
01/20/2005US20050014174 Method for the detection of nucleic acids
01/20/2005US20050014173 Parkinson's disease markers
01/20/2005US20050014170 Using single nucleotide polymorphism as diagnostic/prognostic indicator of neuropsychiatric disorders; identifying modulators for treatment of psychological disorders
01/20/2005US20050014169 Nuclease inhibitor cocktail
01/20/2005US20050014168 Solid support comprised of nucleotide sequences complimentary to 3' prime end of preferential polynucleotides for use as tool in detection of mammary gland cell proliferative disorders; gene expression analysis and cancer diagnosis
01/20/2005US20050014167 Anterior gradient 2 homolog (AGR2) for use as to in identifying modulator for treatment of asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, vision defects, inflammatory bowel and cell proliferative disorders
01/20/2005US20050014166 Compositions and systems for the regulation of genes
01/20/2005US20050014165 Biomarker panel for colorectal cancer
01/20/2005US20050014163 Target-dependent reactions using structure-bridging oligonucleotides
01/20/2005US20050014162 Apparatus and method for threading a biopolymer through a nanopore
01/20/2005US20050014160 Bioconjugates for detecting proteases such as beta-secretase and caspase; solid phase synthesis; high throughput assay; drug screening; kits
01/20/2005US20050014159 Method for detecting a propensity of an individual to response effectively to treatment of interferon-alpha and ribavirin combined therapy
01/20/2005US20050014158 Using presence of polymorphic sequences in gene associated with phospholipase to diagnose, prognose and treat non-insulin dependent diabetes mellitus and obesity
01/20/2005US20050014157 Primers for amplifying hsp 65 gene of mycobacterial species, hsp 65 gene fragments and method of identifying mycobacterial species with the same
01/20/2005US20050014154 Using nucleic acid microarrays to identify, classify and characterize bacteria associated with periodontitis; oral disease diagnosis
01/20/2005US20050014153 Reaction chambers containing complex stable reagent formulations and test kit for detection and isolation of pathogenic microbial nucleic acids